Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal

Most of the current therapies used in the treatment of multiple sclerosis (MS) are either ineffective or have adverse side effects. As such, there is a need to develop better therapies that specifically target myelin-specific aberrant immune cells involved in CNS inflammation without compromising th...

Descripción completa

Detalles Bibliográficos
Autores principales: Badawi, Ahmed H, Kiptoo, Paul, Siahaan, Teruna J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484621/
https://www.ncbi.nlm.nih.gov/pubmed/26140285
http://dx.doi.org/10.4172/2376-0389.1000131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484621/
https://www.ncbi.nlm.nih.gov/pubmed/26140285
http://dx.doi.org/10.4172/2376-0389.1000131

Ejemplares similares